Protein kinases curb cell death

Odile Filhol1, Claude Cochet

  • 1INSERM, Unité 1036, Biology of Cancer and Infection, Grenoble, F-38054, France.

Science Signaling
|May 12, 2011
PubMed

Insights

Protein kinase CK2 globally inhibits programmed cell death by phosphorylating caspases and their substrates. This kinase activity, dysregulated in cancer, contributes to tumorigenesis by suppressing apoptosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Caspases are key executioners of programmed cell death (apoptosis).
  • Protein kinases can phosphorylate caspases and their substrates, suggesting pathway crosstalk.
  • Phosphorylation can inhibit caspase activity by preventing substrate cleavage.

Purpose of the Study:

  • To identify the primary kinase involved in regulating caspase signaling.
  • To investigate the role of this kinase in cancer development.

Main Methods:

  • Literature review and analysis of existing studies on kinase-substrate interactions and caspase signaling.
  • Examination of protein kinase CK2's role in cellular signaling networks.

Main Results:

  • Protein kinase CK2 was identified as a prominent kinase globally inhibiting caspase signaling.
  • CK2 phosphorylates caspases and their substrates, protecting them from cleavage.
  • CK2 dysregulation is implicated in various cancers, promoting cell growth and inhibiting apoptosis.

Conclusions:

  • Protein kinase CK2's ability to inhibit caspase activity contributes to its oncogenic potential.
  • CK2's role in suppressing apoptosis is a key mechanism in tumorigenesis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...